Novo Nordisk A/S (BVMF:N1VO34)

Novo Nordisk Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,442,081	2,380,287	2,239,577	1,609,379	1,427,474	842,033
Market Cap Growth	-41.16%	6.28%	39.16%	12.74%	69.53%	53.39%
Enterprise Value	1,499,353	2,364,911	2,224,424	1,600,641	1,409,030	823,790
Last Close Price	41.22	66.14	60.78	42.69	-	-
PE Ratio	16.60	27.45	37.19	38.16	35.07	23.41
PS Ratio	5.46	9.55	13.40	11.97	11.90	7.77
PB Ratio	10.14	19.32	29.21	25.38	23.68	15.58
P/TBV Ratio	27.21	85.58	67.43	65.10	60.74	23.12
P/FCF Ratio	26.11	37.56	37.45	31.75	34.42	21.39
P/OCF Ratio	13.91	22.92	28.58	26.86	30.45	18.99
EV/Sales Ratio	5.69	9.49	13.31	11.91	11.74	7.60
EV/EBITDA Ratio	10.76	18.78	27.97	25.98	25.93	16.48
EV/EBIT Ratio	11.69	19.69	29.53	27.87	27.92	17.83
EV/FCF Ratio	27.15	37.32	37.20	31.57	33.97	20.93
Debt / Equity Ratio	0.60	0.72	0.25	0.31	0.38	0.16
Debt / EBITDA Ratio	0.61	0.69	0.24	0.31	0.41	0.17
Debt / FCF Ratio	1.53	1.39	0.33	0.39	0.55	0.23
Asset Turnover	0.69	0.74	0.84	0.81	0.83	0.94
Inventory Turnover	1.22	1.20	1.26	1.29	1.24	1.16
Quick Ratio	0.53	0.52	0.62	0.67	0.65	0.64
Current Ratio	0.78	0.74	0.82	0.90	0.86	0.94
Return on Equity (ROE)	71.47%	80.77%	88.07%	72.00%	71.24%	69.70%
Return on Assets (ROA)	21.11%	22.41%	23.55%	21.69%	21.81%	25.01%
Return on Capital (ROIC)	42.81%	46.03%	53.89%	45.74%	43.27%	49.84%
Return on Capital Employed (ROCE)	55.30%	56.30%	72.30%	62.80%	62.30%	72.50%
Earnings Yield	6.02%	3.64%	2.69%	2.62%	2.85%	4.27%
FCF Yield	3.83%	2.66%	2.67%	3.15%	2.90%	4.67%
Dividend Yield	2.11%	14.80%	11.13%	11.03%	-	-
Payout Ratio	49.88%	43.71%	37.96%	45.57%	45.05%	47.75%
Buyback Yield / Dilution	0.46%	0.71%	1.10%	1.34%	1.58%	1.63%
Total Shareholder Return	2.57%	15.50%	12.23%	12.37%	1.58%	1.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.